Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 16 11 2022
accepted: 26 03 2023
revised: 14 03 2023
medline: 27 10 2023
pubmed: 31 5 2023
entrez: 31 5 2023
Statut: ppublish

Résumé

We conducted a systematic review and individual participant data meta-analysis of publications reporting the ophthalmologic presentation, clinical exam, and orbital MRI findings in patients with giant cell arteritis and ocular manifestations. PubMed and Cochrane databases were searched up to January 16, 2022. Publications reporting patient-level data on patients with ophthalmologic symptoms, imaged with orbital MRI, and diagnosed with biopsy-proven giant cell arteritis were included. Demographics, clinical symptoms, exam, lab, imaging, and outcomes data were extracted. The methodological quality and completeness of reporting of case reports were assessed. Thirty-two studies were included comprising 51 patients (females = 24; median age, 76 years). Vision loss (78%) and headache (45%) were commonly reported visual and cranial symptoms. Ophthalmologic presentation was unilateral (41%) or bilateral (59%). Fundus examination most commonly showed disc edema (64%) and pallor (49%). Average visual acuity was very poor (2.28 logMAR ± 2.18). Diagnoses included anterior (61%) and posterior (16%) ischemic optic neuropathy, central retinal artery occlusion (8%), and orbital infarction syndrome (2%). On MRI, enhancement of the optic nerve sheath (53%), intraconal fat (25%), and optic nerve/chiasm (14%) was most prevalent. Among patients with monocular visual symptoms, 38% showed pathologic enhancement in the asymptomatic orbit. Six of seven cases reported imaging resolution after treatment on follow-up MRIs. Vision loss, pallid disc edema, and optic nerve sheath enhancement are the most common clinical, fundoscopic, and imaging findings reported in patients diagnosed with giant cell arteritis with ocular manifestations, respectively. MRI may detect subclinical inflammation and ischemia in the asymptomatic eye and may be an adjunct diagnostic tool. Brain and orbital MRIs may have diagnostic and prognostic roles in patients with suspected giant cell arteritis who present with ophthalmic symptoms.

Identifiants

pubmed: 37256352
doi: 10.1007/s00330-023-09770-2
pii: 10.1007/s00330-023-09770-2
doi:

Types de publication

Systematic Review Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7913-7922

Subventions

Organisme : NEI NIH HHS
ID : L30 EY029353
Pays : United States
Organisme : NEI NIH HHS
ID : NEI/K08EY029765
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to European Society of Radiology.

Références

Hayreh SS, Podhajsky PA, Zimmerman B (1998) Ocular manifestations of giant cell arteritis. Am J Ophthalmol 125:509–520
pubmed: 9559737
Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123:192–194
pubmed: 7598301
Chandran AK, Udayakumar PD, Crowson CS, Warrington KJ, Matteson EL (2015) The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950–2009. Scand J Rheumatol 44:215–218
pubmed: 25606666 pmcid: 4431922
Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County. Arthritis Rheum 26:1214–1219
pubmed: 6626279
Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51:264–268
pubmed: 15077270
Saleh M, Turesson C, Englund M, Merkel PA, Mohammad AJ (2016) Visual complications in patients with biopsy-proven giant cell arteritis: a population-based study. J Rheumatol 43:1559–1565
pubmed: 27252424 pmcid: 7350139
Ji J, Dimitrijevic I, Sundquist J, Sundquist K, Zöller B (2017) Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden. Scand J Rheumatol 46:484–489
pubmed: 28276953
González-Gay MA, García-Porrúa C, Llorca J et al (2000) Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 79:283–292
pubmed: 11039076
Costello F, Zimmerman MB, Podhajsky PA, Hayreh SS (2004) Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol 14:245–257
pubmed: 15206651
D’Souza NM, Morgan ML, Almarzouqi SJ, Lee AG (2016) Magnetic resonance imaging findings in giant cell arteritis. Eye (Lond) 30:758–762
pubmed: 26915748
Berger CT, Sommer G, Aschwanden M, Staub D, Rottenburger C, Daikeler T (2018) The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis. Swiss Med Wkly 148:w14661
pubmed: 30141518
Bley TA, Wieben O, Uhl M, Thiel J, Schmidt D, Langer M (2005) High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 184:283–287
pubmed: 15615989
Mohammed-Brahim N, Clavel G, Charbonneau F et al (2019) Three Tesla 3D high-resolution vessel wall MRI of the orbit may differentiate arteritic from nonarteritic anterior ischemic optic neuropathy. Invest Radiol 54:712–718
pubmed: 31335635
Guggenberger KV, Vogt ML, Song JW et al (2022) Intraorbital findings in giant cell arteritis on black blood MRI. Eur Radiol. https://doi.org/10.1007/s00330-022-09256-7
doi: 10.1007/s00330-022-09256-7 pubmed: 36394601 pmcid: 10017783
AlShaker S, Shemesh AA, Margolin E (2018) Enhancement of optic nerve sheath in AAION: a case of visual recovery in fulminant GCA. Can J Ophthalmol 53:e236–e239
pubmed: 30503002
Lee AG, Eggenberger ER, Kaufman DI, Manrique C (1999) Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuroophthalmol 19:235–237
pubmed: 10608674
Nambiema A, Sembajwe G, Lam J et al (2021) A protocol for the use of case reports/studies and case series in systematic reviews for clinical toxicology. Front Med (Lausanne) 8:708380
pubmed: 34552944
Tierney JF SL, Clarke M (2022) Chapter 26: individual partcipant data. In: Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors), (ed) Cochrane Handbook for Systematic Reviews of Interventions version 63. Cochrane
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D (2014) The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 67:46–51
pubmed: 24035173
Institute JB (2017) Checklist for Case Reports. The Joana Briggs Institute, www.joannabriggs.org . Available via https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Case_Reports2017_0.pdf . Accessed November 10, 2022 2022
Holladay JT (2004) Visual acuity measurements. J Cataract Refract Surg 30:287–290
pubmed: 15030802
Kniestedt C, Stamper RL (2003) Visual acuity and its measurement. Ophthalmol Clin North Am 16:155–170
pubmed: 12809155
Virgili G, Acosta R, Bentley SA, Giacomelli G, Allcock C, Evans JR (2018) Reading aids for adults with low vision. Cochrane Database Syst Rev 4:Cd003303
Kim DD, Budhram A, Pelz D, MacDonald M (2016) Teaching neuroimages: orbital infarction syndrome from giant cell arteritis. Neurology 87:e269
pubmed: 27895251
Lee AG, Tang RA, Feldon SE et al (2001) Orbital presentations of giant cell arteritis. Graefes Arch Clin Exp Ophthalmol 239:509–513
pubmed: 11521695
Gospe SM 3rd, Amrhein TJ, Malinzak MD, Bhatti MT, Mettu P, El-Dairi MA (2021) Magnetic resonance imaging abnormalities of the optic nerve sheath and intracranial internal carotid artery in giant cell arteritis. J Neuroophthalmol 41:54–59
pubmed: 31609845
Liu KC, Chesnutt DA (2013) Perineural optic nerve enhancement on magnetic resonance imaging in giant cell arteritis. J Neuroophthalmol 33:279–281
pubmed: 23845995
Emami S, Howarth D, Margolin E (2021) Giant cell arteritis presenting as bilateral optic perineuritis in an african man. J Neuroophthalmol 41:e149–e152
pubmed: 32324643
Tashiro T, Tsujimoto A, Nakamura N (2021) Ischemic optic neuropathy despite pulse methylprednisolone therapy in a giant cell arteritis patient with perineural optic nerve enhancement. Rinsho Shinkeigaku 61:851–855
pubmed: 34789629
Geiger J, Ness T, Uhl M et al (2009) Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. Rheumatology (Oxford) 48:537–541
pubmed: 19233887
Ross M, Bursztyn L, Superstein R, Gans M (2017) Multiple cranial nerve palsies in giant cell arteritis. J Neuroophthalmol 37:398–400
pubmed: 28538036
Albarrak AM, Mohammad Y, Hussain S, Husain S, Muayqil T (2018) Simultaneous bilateral posterior ischemic optic neuropathy secondary to giant cell arteritis: a case presentation and review of the literature. BMC Ophthalmol 18:317
pubmed: 30541489 pmcid: 6292061
Biotti D, Savatovski J, Bidot S et al (2011) Diffusion MR imaging of the optic nerve in a patient with giant-cell arteritis and vertebral artery vasculitis. Eur Neurol 66:83–84
pubmed: 21778731
Garcia-Porrua C, Santamarina R, Armesto V, Gonzalez-Gay MA (2005) Magnetic resonance imaging in optic neuritis due to giant cell arteritis. Arthritis Rheum 53:313–314
pubmed: 15818643
Heraud A, Zmuda M, Lecler A (2018) Lacrimal gland ischemia due to giant cell arteritis. Ophthalmology 125:1233
pubmed: 30032795
Garcia-Porrua C, Pego-Reigosa R, Armesto V, Gonzalez-Gay MA (2003) Neovascularization around the optic nerve in giant cell arteritis. Arthritis Rheum 49:737–738
pubmed: 14558066
Kornberg MD, Ratchford JN, Subramaniam RM, Probasco JC (2015) Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves. BMJ Case Rep 2015
Donaldson L, Nanji K, Rebello R, Khalidi NA, Rodriguez AR (2020) Involvement of the intracranial circulation in giant cell arteritis. Can J Ophthalmol 55:391–400
pubmed: 32416931
Hittinger M, Berlis A, Pfadenhauer K (2015) Inflammatory Pseudo-tumour Orbitae (PTO): an atypical manifestation of giant cell arteritis (GCA). Clin Neuroradiol 25:411–414
pubmed: 25231428
Morgenstern KE, Ellis BD, Schochet SS, Linberg JV (2003) Bilateral optic nerve sheath enhancement from giant cell arteritis. J Rheumatol 30:625–627
pubmed: 12610827
Joelson E, Ruthrauff B, Ali F, Lindeman N, Sharp FR (2000) Multifocal dural enhancement associated with temporal arteritis. Arch Neurol 57:119–122
pubmed: 10634458
Nassani S, Cocito L, Arcuri T, Favale E (1995) Orbital pseudotumor as a presenting sign of temporal arteritis. Clin Exp Rheumatol 13:367–369
pubmed: 7554567
Choi JH, Shin JH, Jung JH (2019) Arteritic anterior ischemic optic neuropathy associated with giant-cell arteritis in Korean patients: a retrospective single-center analysis and review of the literature. J Clin Neurol 15:386–392
pubmed: 31286712 pmcid: 6620454
Hayreh SS (2021) Giant cell arteritis: its ophthalmic manifestations. Indian J Ophthalmol 69:227–235
pubmed: 33463564 pmcid: 7933845
Killer HE, Laeng HR, Flammer J, Groscurth P (2003) Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations. Br J Ophthalmol 87:777–781
pubmed: 12770980 pmcid: 1771732
Hayreh SS (1991) Ophthalmic features of giant cell arteritis. Baillieres Clin Rheumatol 5:431–459
pubmed: 1807820
Zhang K-J, Li M-X, Zhang P, Qin H-Q, Guo Z-N, Yang Y (2022) Validity of high resolution magnetic resonance imaging in detecting giant cell arteritis: a meta-analysis. Eur Radiol 32:3541–3552
pubmed: 35015125
Duftner C, Dejaco C, Sepriano A, Falzon L, Schmidt WA, Ramiro S (2018) Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open 4:e000612
pubmed: 29531788 pmcid: 5845406
Dejaco C, Ramiro S, Duftner C et al (2018) EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77:636–643
pubmed: 29358285
Gaier ED, Gilbert AL, Cestari DM, Miller JB (2018) Optical coherence tomographic angiography identifies peripapillary microvascular dilation and focal non-perfusion in giant cell arteritis. Br J Ophthalmol 102:1141–1146
pubmed: 29122818
Chen JJ, AbouChehade JE, Iezzi R Jr, Leavitt JA, Kardon RH (2017) Optical coherence angiographic demonstration of retinal changes from chronic optic neuropathies. Neuroophthalmology 41:76–83
pubmed: 28348629 pmcid: 5354095
Tuckwell K, Collinson N, Dimonaco S et al (2017) Newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial. Semin Arthritis Rheum 46:657–664
pubmed: 27998620
Brekke LK, Diamantopoulos AP, Fevang BT, Aβmus J, Esperø E, Gjesdal CG (2017) Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study. Arthritis Res Ther 19:278
pubmed: 29246164 pmcid: 5732381
Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology (Oxford) 38:1208–1212
pubmed: 10587547
Ashton-Key MR, Gallagher PJ (1992) False-negative temporal artery biopsy. Am J Surg Pathol 16:634–635
pubmed: 1599042
López JM, Nazabal ER, Muñiz AM, Rey del Corral P (2001) Detection of posterior ischemic optic neuropathy due to giant cell arteritis with magnetic resonance imaging. Eur Neurol 46:109–110
pubmed: 11528166
Botella-Ortiz AJ, Pampliega-Pérez A, Martín-Estefanía C, Alfaro-Sáez A, Concepción L, Teruel A (2004) The value of orbit magnetic resonance imaging in the diagnosis of blindness caused by giant cell arteritis. Rev Neurol 38:1149–1152
pubmed: 15229829
Mitchell JR, Krashin-Bichler I, Rosenblum M, Diamond EL, Dinkin MJ (2014) Giant cell arteritis presenting with bilateral orbital inflammatory disease and enhancing superficial temporal arteries. Pract Neurol 14:446–447
pubmed: 24853667 pmcid: 4251305
Attaseth T, Vanikieti K, Poonyathalang A, Preechawat P, Jindahra P, Wattanatranon D (2015) Anterior ischemic optic neuropathy due to biopsy-proven giant cell arteritis in Thai patients. Clin Ophthalmol 9:1071–1075
pubmed: 26109841 pmcid: 4472068
Chen JJ, Kardon RH, Daley TJ, Longmuir RA (2015) Enhancement of the optic nerve sheath and temporal arteries from giant cell arteritis. Can J Ophthalmol 50:e96-97
pubmed: 26455993
Mears KA, Feinsilber D (2020) High-sensitivity C-reactive protein and magnetic resonance imaging in occult giant cell arteritis. Cureus 12:e9530
pubmed: 32775116 pmcid: 7402541
Serrano Alcalá E, Grivé Isern E, Díez Borras L, Salaya Díaz JT (2020) Orbital Magnetic Resonance Imaging to unmask giant cell arteritis. Radiologia (Engl Ed) 62:160–163
pubmed: 31889535
Panneerselvam S, Raviskanthan S, Mortensen PW, Lee AG (2021) giant cell arteritis presenting as central retinal artery occlusion and optic perineuritis: the importance of contrast MRI of the orbit. J Neuroophthalmol. https://doi.org/10.1097/wno.0000000000001415
doi: 10.1097/wno.0000000000001415 pubmed: 34924534

Auteurs

Konstanze V Guggenberger (KV)

Department of Radiology, University of Würzburg, Würzburg, Germany.

Athanasios Pavlou (A)

Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Department of Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Quy Cao (Q)

Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, USA.

Ishaan J Bhatt (IJ)

Drexel University College of Medicine, Philadelphia, PA, USA.

Qi N Cui (QN)

Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, USA.

Thorsten A Bley (TA)

Department of Radiology, University of Würzburg, Würzburg, Germany.

Hugh D Curtin (HD)

Department of Radiology, Harvard Medical School, Massachusetts Eye and Ear, Boston, MA, USA.

Julien Savatovsky (J)

Department of Radiology, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.

Jae W Song (JW)

Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA. jae.song@pennmedicine.upenn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH